Critical appraisal of medical devices in the management of cerebrovascular disease.

Therapeutics and Clinical Risk Management
Michael J Schneck

Abstract

Medical devices may revolutionize the management of acute ischemic stroke and prevention of recurrent events. By comparison with pharmaceuticals, the device approval process and subsequent application of these devices in stroke treatment is founded on a paucity of Class I evidence-based clinical trial data. Thromboembolectomy for acute stroke, stenting of cervical or cerebral arteries for stroke prevention, and percutaneous closure of patent foramen ovale for prevention or recurrent cerebral ischemia are being done with an ever-increasing frequency despite few, if any, randomized clinical trials to confirm the appropriateness of the interventions. The current basis, or lack thereof, for these interventions for cerebrovascular disease is therefore discussed. As such, a critical appraisal of the available clinical data does not support widespread use of medical devices at this time outside of well-designed clinical trials.

Methods Mentioned

BETA
dissection

Software Mentioned

NEUROLINK
CAPTURE
SPACE
WINGSPAN
PICSS
SAPPHIRE
EVA
3S
CREST

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Related Papers

Journal of the American College of Cardiology
Elad I LevyL Nelson Hopkins
Journal of the American College of Cardiology
Shelby KuttyBijoy K Khandheria
Neurologic Clinics
Qasim BashirVictor Aletich
© 2022 Meta ULC. All rights reserved